News | June 22, 2022
Agilent Laboratory achieves Green Lab certification
This is the first Agilent lab to receive the My Green Lab Certification and plans are under way to certify additional labs.
This is the first Agilent lab to receive the My Green Lab Certification and plans are under way to certify additional labs.
This investment will facilitate a Cipla entity's strategic participation in the Poe diagnostics and AMR space through the design, development, and manufacturing of microfluidics-based technologies
Ganguly will execute company's strategic focus on leveraging CustomGlycan to develop novel therapeutics
We see significant potential in working with oncolytic virus companies and Neo antigen-companies
Many kids who have heart transplants live a normal, healthy life once they recover from surgery.
The three-year collaboration will focus on the development of new tools for computational chemistry modelling as well as new molecular representations to advance the next generation of molecular machine learning
This new formulation represents a significant improvement over protease inhibitor-containing paediatric ARV formulations that have been used in South Africa for decades.
Gilman will be responsible for all business development and portfolio strategy efforts globally.
Tislelizumab is now approved in nine indications in China
A research group led by Ben-Gurion University of the Negev managed to produce an innovative microchip for creating sperm in a culture by using a microfluidic system.
Subscribe To Our Newsletter & Stay Updated
